Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line

Eric A. Jaffe, Douglas Armellino, Douglas M. Tollefsen

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Human plasma heparin cofactor II (HCII) inhibits thrombin by rapidly forming a stable, equimolar complex in the presence of heparin or dermatan sulfate. Cultured human hepatoma-derived cells ( PLC PRF-5) secreted (≈200 ng/ml in 3 days) a protein of MW - 72 kD that was immunoisolated and immunoblotted with anti-HCII, co-migrated on SDS-PAGE with human plasma HCII, and formed covalent complexes with thrombin (MW - 101 kD) in the presence but not absence of heparin or dermatan sulfate; these complexes co-migrated with those obtained by incubating thrombin with human plasma under the same conditions. HCII was not detectable (< 0.13 ng/ml) in post-culture medium from cultured human umbilical vein endothelial cells or human foreskin fibroblasts.

Original languageEnglish
Pages (from-to)368-374
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume132
Issue number1
DOIs
StatePublished - Oct 15 1985

Fingerprint

Dive into the research topics of 'Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line'. Together they form a unique fingerprint.

Cite this